A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.

Clinical trial NCT07357675 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07357675
Sponsor: EBI Anti Sepsis BV
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease (CAD)Coronary Artery Bypass Graft Surgery(CABG)

Start date: 2026-08-01
Primary completion: 2027-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.